Search results
Results from the WOW.Com Content Network
Pages in category "Pharmaceutical companies of the Philippines" The following 3 pages are in this category, out of 3 total. This list may not reflect recent changes .
Unilab, Inc., commonly known as Unilab (stylized in all caps), is a Philippine pharmaceutical company headquartered in Mandaluyong, Metro Manila. [1] It specializes in a wide range of consumer healthcare products such as prescription and over-the counter medications, vitamins and food supplements, and biotechnology.
Cathay Drug is recognized as one of the fastest-growing pharmaceutical companies in the Philippines. In 2012, it was included in the Top 20 Leading Philippine Pharmaceutical Companies based on Value in the Philippine Pharmaceutical Industry Audit [2] for ethical segment by IMS. It was also ranked second among national pharmaceutical companies ...
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider [5] The name of the modern company honors the legacy organizations.
The chain was founded in Santa Cruz, Manila in 1945, [1] making it the second oldest drugstore chain in the Philippines after Southstar Drug by eight years. As of 2017, Mercury Drug has over 1,000 branches nationwide [ 6 ] and over 50 percent of the Philippine pharmaceutical retail market.
In 1888, the company introduced the first tramcar service in the Philippines. The company participated in the construction of the Ayala Bridge over the Pasig River in Manila. Originally built of wood in 1872, the bridge was reconstructed in steel in 1908 to become the first steel bridge in the Philippines.
The head office is situated at Stockholmer Platz in the new Europaviertel of Stuttgart, next to Stadtbibliothek and Milaneo shopping centre. The company's core business consists of pharmaceutical wholesale and pharmacies. In the pharmaceutical wholesaling sector, McKesson Europe has a market presence in 14 countries.
About four hundred and eighty (480) candidates are accepted into the First-Year level of the Doctor of Medicine (M.D.) program yearly. A percentage of slots is reserved for UST graduates. Foreign students comprise about 5% to 7% of the total first-year population. Among this number, approximately 80% are graduates of UST.